05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Clinical trial NCT00400946 · COMPLETED

Trial details

NCT number: NCT00400946
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Drug/Agent Toxicity by Tissue/Organ Leukemia

Start date: 2005-04-01
Primary completion: 2014-08-01
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.